Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Johnson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|May 24, 2024
Changes in Inhaled Nitric Oxide Use Across ICUs After Implementation of a Standard PathwayMonique Radman, John McGuire, Paul Sharek, et al.
Pediatrics|February 23, 2018
Neonatal Jaundice: Improved Quality and Cost Savings After Implementation of a Standard PathwayHolly M Romero, Coral Ringer, Michael G Leu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
A randomized open-label, observational study of the novel ketone ester, bis octanoyl (R)-1,3-butanediol, and its acute effect on ß-hydroxybutyrate and glucose concentrations in healthy older adultsElizabeth B Stephens, Chatura Senadheera, Stephanie Roa-Diaz, et al.
Journal of Nutrition in Gerontology and Geriatrics|February 22, 2025
A Randomized Open-Label, Observational Study of the Novel Ketone Ester, Bis Octanoyl (R)-1,3-Butanediol, and Its Acute Effect on ß-Hydroxybutyrate and Glucose Concentrations in Healthy Older AdultsElizabeth B Stephens, Chatura Senadheera, Stephanie Roa-Diaz, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Daily consumption of ketone ester, bis-octanoyl (R)-1,3-butanediol, is safe and tolerable in healthy older adults, a randomized, parallel arm, double-blind, placebo-controlled, pilot studyBrianna J Stubbs, Elizabeth B Stephens, Chatura Senadheera, et al.
The Journal of Nutrition, Health & Aging|August 13, 2024
Daily consumption of ketone ester, bis-octanoyl (R)-1,3-butanediol, is safe and tolerable in healthy older adults in a randomized, parallel arm, double-blind, placebo-controlled, pilot studyBrianna J Stubbs, Elizabeth B Stephens, Chatura Senadheera, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Rationale and protocol for a safety, tolerability and feasibility randomized, parallel group, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanismsBrianna J Stubbs, Gabriela Alvarez-Azanedo, Sawyer Peralta, et al.
Plos One|September 18, 2024
Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanismsBrianna J Stubbs, Gabriela Alvarez Azañedo, Sawyer Peralta, et al.
Free Radical Biology & Medicine|February 13, 2007
Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthmaJames B Johnson, Warren Summer, Roy G Cutler, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Exploratory functional and quality of life outcomes with daily consumption of the ketone ester bis-octanoyl (R)-1,3-butanediol in healthy older adults: a randomized, parallel arm, double-blind, placebo-controlled studyBrianna J Stubbs, Elizabeth B Stephens, Chatura Senadheera, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|May 24, 2024
Changes in Inhaled Nitric Oxide Use Across ICUs After Implementation of a Standard PathwayMonique Radman, John McGuire, Paul Sharek, et al.
Pediatrics|February 23, 2018
Neonatal Jaundice: Improved Quality and Cost Savings After Implementation of a Standard PathwayHolly M Romero, Coral Ringer, Michael G Leu, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
A randomized open-label, observational study of the novel ketone ester, bis octanoyl (R)-1,3-butanediol, and its acute effect on ß-hydroxybutyrate and glucose concentrations in healthy older adultsElizabeth B Stephens, Chatura Senadheera, Stephanie Roa-Diaz, et al.
Journal of Nutrition in Gerontology and Geriatrics|February 22, 2025
A Randomized Open-Label, Observational Study of the Novel Ketone Ester, Bis Octanoyl (R)-1,3-Butanediol, and Its Acute Effect on ß-Hydroxybutyrate and Glucose Concentrations in Healthy Older AdultsElizabeth B Stephens, Chatura Senadheera, Stephanie Roa-Diaz, et al.
Medrxiv : the Preprint Server for Health Sciences|May 15, 2024
Daily consumption of ketone ester, bis-octanoyl (R)-1,3-butanediol, is safe and tolerable in healthy older adults, a randomized, parallel arm, double-blind, placebo-controlled, pilot studyBrianna J Stubbs, Elizabeth B Stephens, Chatura Senadheera, et al.
The Journal of Nutrition, Health & Aging|August 13, 2024
Daily consumption of ketone ester, bis-octanoyl (R)-1,3-butanediol, is safe and tolerable in healthy older adults in a randomized, parallel arm, double-blind, placebo-controlled, pilot studyBrianna J Stubbs, Elizabeth B Stephens, Chatura Senadheera, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Rationale and protocol for a safety, tolerability and feasibility randomized, parallel group, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanismsBrianna J Stubbs, Gabriela Alvarez-Azanedo, Sawyer Peralta, et al.
Plos One|September 18, 2024
Rationale and protocol for a safety, tolerability and feasibility randomized, parallel arm, double-blind, placebo-controlled, pilot study of a novel ketone ester targeting frailty via immunometabolic geroscience mechanismsBrianna J Stubbs, Gabriela Alvarez Azañedo, Sawyer Peralta, et al.
Free Radical Biology & Medicine|February 13, 2007
Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthmaJames B Johnson, Warren Summer, Roy G Cutler, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Exploratory functional and quality of life outcomes with daily consumption of the ketone ester bis-octanoyl (R)-1,3-butanediol in healthy older adults: a randomized, parallel arm, double-blind, placebo-controlled studyBrianna J Stubbs, Elizabeth B Stephens, Chatura Senadheera, et al.
Pageof 3